Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy vs Hydrocortisone in Septic Shock
NCT04508946Phase 3Completed
- Sponsor
- PLA Air Force Characteristic Medical Center
- Start
- Aug 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid, thiamine in septic shock, sponsored by PLA Air Force Characteristic Medical Center. Started Aug 2019; status: completed.
02
Drugs
ascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04508946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04508946.